Peter Doherty Institute of Infection and Immunity (Doherty Institute) Feb 12 2025 Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in collaboration with Pfizer, have discovered new insights into possible future treatments for breast cancer.  A new dual-target drug that has been shown to supercharge cancer-fighting immune cells in mice may support a

Tag-uri: Pfizer